Explore our advanced medical-grade products, high-efficiency aseptic filling systems, and custom medical devices engineered for optimized fluid recovery.
In critical healthcare settings, the efficacy of vaccine delivery, biological oncology therapies, and personalized micro-dosing relies heavily on minimizing residual waste. Standard syringes often trap up to 0.084 milliliters of medicine in the "dead zone" at the tip and within the needle hub. Low Dead Space (LDS) syringes address this inefficiency directly by integrating precise mechanical structures that reduce residual volume to under 0.002 milliliters.
As a leading name in high-end medical consumables manufacture, Hangzhou JZCare Medical Co., Ltd. spearheads the development of global-grade sterile injection mechanisms. Founded in 2011, JZCare utilizes advanced high-tolerance automated cleanroom systems to manufacture medical devices that prioritize patient safety and maximize active dosage retrieval, assisting healthcare systems worldwide in securing the maximum health value from every single vial.
Standard injection tools have structural voids where the plunger cannot fully reach the needle tip connection point. Our research team has reimagined the internal topography of both the barrel interior and plunger interface, offering a mechanical shift that saves millions of dollars globally in vaccine campaigns.
By implementing a precision-designed elongated silicone rubber tip, the JZCare LDS plunger extends directly inside the needle canal. This mechanical displacement pushes trapped fluids out of the dead space, mitigating wastage of expensive gene-therapies, vaccines, or localized dermal treatments.
Designed with exceptional dimensional tolerance controls, the connection adapter coordinates flawlessly with both standard and specialty micro-needles. Standardized luer-lock threads provide a robust airtight hermetic lock, eliminating fluid leakage during high-pressure clinical applications.
Constructed utilizing ultra-clear, medical-grade raw polypropylene sourced from top global suppliers. The crystal-clear barrel allows nursing staff to identify micro-bubbles, while the medical elastomer gasket prevents contamination from common synthetic latex derivatives.
| Performance Metric | Traditional High Dead Space (HDS) | JZCare Low Dead Space (LDS) | Clinical Value Realized |
|---|---|---|---|
| Mean Residual Fluid Volume | 0.075 ml to 0.084 ml | < 0.002 ml to 0.008 ml | Reduces clinical fluid loss by over 90% |
| Doses Harvested (per 5-dose vial) | 5 nominal doses | 6 complete active doses | 20% immediate increase in vaccination yield |
| Plunger Interface Design | Flat profile elastomer head | Extended mechanical plunger protrusion | Fills empty tip and needle connector zones |
| Bubble Risk and Visibility | Moderate - obscure hub design | Optimized crystalline transparency | Fewer micro-bubbles, enhanced safety profile |
| Application Recommendation | General low-cost saline fluid injection | High-value therapeutics, insulin, vaccines | Saves substantial costs per single treatment cycle |
As global medicine moves toward personalized biologics, gene therapies, and mRNA-based oncology vaccines, the design paradigm of disposable medical devices is undergoing a revolutionary shift. JZCare is at the forefront of this evolution, investing in key research areas that define the next decade of injection technology.
Conforming to worldwide carbon-reduction mandates, JZCare's chemical engineers are testing plant-derived medical-grade biopolymers. By shifting away from standard hydrocarbon-derived plastics, we aim to decrease our carbon footprint while maintaining identical chemical inertness, high durability, and absolute biocompatibility during long-term storage.
Future patient therapies will rely heavily on painless self-administration. Our engineering pipeline is standardizing LDS syringe bodies integrated with ultra-thin 32G and 34G painless micro-needles. These micro-needles maintain optimized flow rates while decreasing patient discomfort, making them ideal for high-frequency applications like pediatric vaccinations and chronic insulin therapy.
To reduce clinical dosing errors, JZCare is developing color-shifting plunger coatings and digital micro-scales. These high-visibility markings allow medical professionals to visually confirm that the exact volume of medication has been dispensed. This helps secure patient treatment integrity in fast-paced ICU environments and during large-scale emergency response initiatives.
Lyophilized biological therapeutics require rapid reconstitution before patient injection. JZCare's long-term roadmap features dual-chamber LDS syringes designed to isolate dry powder active ingredients from sterile liquid diluents, utilizing our low dead space chamber seals to ensure zero residual loss during high-precision compound mixing.
Our high-capacity facility in Hangzhou, China, operates on automated manufacturing principles. Built over a modern 26,000 square meter landscape, our Factory 4.0 framework ensures that JZCare delivers exceptional, reliable products directly to your distribution center.
Our ISO-certified Class 100,000 cleanroom environments control ambient particulate counts, temperature fluctuations, and relative humidity, satisfying international sanitary guidelines and preventing foreign material ingress.
From precision multi-cavity injection molding machines to automatic visual inspection systems, our automated workflows reduce human error, achieving a low defect rate and highly uniform needle dimensions.
We validate every manufacturing batch using reliable Ethylene Oxide (EO) gas sterilization procedures. Extensive laboratory assays, colorimetric biological indicators, and physical tests ensure all products remain sterile prior to delivery.
As a trusted international supplier, JZCare streamlines medical procurement for ministries of health, multinational pharmaceutical companies, and established hospital equipment distributors. We guarantee absolute compliance, robust production volume scalability, and professional logistics management.
Our production environment operates under the certified framework of ISO 13485:2016. Every batch undergoes rigorous quality controls, maintaining conformance to the European Union Medical Device Regulation (EU MDR 2017/745) and US FDA requirements, ensuring a smooth path through customs clearance processes.
We accommodate customized specifications to meet unique market needs. Options include specialized safety needle caps, varied barrel colorations, multi-lingual blister packaging, custom print scales, and complete high-barrier Tyvek medical packaging options.
Located in Hangzhou, China, JZCare is situated near major deepwater shipping ports in Ningbo and Shanghai. Our logistical network coordinates closely with international container liners, air cargo operations, and door-to-port multimodal transport networks, assuring secure, timely deliveries.
We provide full regulatory assistance files (including CE Technical Files and DMF documentation) to support your local registration requirements, expediting market authorization and reducing administrative delays.
Below are technical answers and details addressing common inquiries from medical quality auditors, pharmaceutical companies, and supply chain managers.
An LDS syringe is specifically engineered to reduce fluid dead space (the area inside the needle hub and the tip of the syringe barrel where liquid remains after injection). Traditional syringes retain up to 0.084 ml of fluid. JZCare's LDS syringes reduce this volume to under 0.008 ml (and under 0.002 ml for integrated-needle models), minimizing chemical residue and wastage of valuable medications.
The core difference lies in the plunger and tip design. JZCare utilizes high-precision micro-injection molding to create a protruding silicone plunger tip that matches the internal shape of the luer hub. When pressed, this protrusion displaces fluid from the empty hub, which is otherwise unreachable in standard flat-plunger syringes.
All JZCare medical disposables undergo a validated Ethylene Oxide (EO) sterilization process conforming to ISO 11135 regulations. Each batch is quarantined until biological indicators confirm a sterility assurance level (SAL) of 10^-6, followed by physical inspection before shipment.
Yes. JZCare offers comprehensive OEM and ODM support, including customized blister packs, polybags, multi-lingual instructions, and shipping cartons that comply with local regulatory guidelines, such as UDI (Unique Device Identification) and GS1 barcodes.
Standard export MOQs are determined by product categories, generally starting at 100,000 units for standard disposable products. Production lead times average 30 to 45 days, depending on custom requirements and shipping routes.
Explore more sterile hypodermic needles, dental anesthesia syringes, and robust high-grade anesthesia devices from our global inventory.
JZCare Syringe
